Demonstration of 1000 fps High-Speed Angiography (HSA) in Pre-Clinical In-vivo Rabbit Aneurysm Models During Flow-Diverter Treatment.

High Speed Angiography (HSA) at 1000 fps is a novel interventional-imaging technique that was previously used to visualize changes in vascular flow details before and after flow-diverter treatment of cerebral aneurysms in in-vitro 3D printed models. In this first pre-clinical work, we demonstrate the use of the HSA technique during flow-diverter treatment of in-vivo rabbit aneurysm models. An aneurysm was created in the right common carotid artery of each of two rabbits using previously published elastase aneurysm-creation methods.

Evaluation of aneurysm flow divertor (stent) treatment using multi-angled 1000 fps High-Speed Angiography (HSA) and Optical Flow (OF).

Understanding detailed hemodynamics is critical in the treatment of aneurysms and other vascular diseases; however, traditional digital subtraction angiography (DSA) does not provide detailed quantitative flow information. Instead, 1000 fps High-Speed Angiography (HSA) can be used for high-temporal visualization and evaluation of detailed blood flow patterns and velocity distributions. In the treatment of aneurysms, flow diverter expansion and positioning play a critical role in affecting the hemodynamics and optimal patient outcomes.

Fluoroscopic Procedure-Room Scatter-Dose Reduction Using a Region-of-Interest (ROI) Attenuator.

During fluoroscopically-guided interventional (FGI) procedures, dose to the patient as well as the scatter dose to staff can be high. However, a significant dose reduction can be possible by using a region-of-interest (ROI) attenuator that reduces the x-ray intensity in the peripheral x-ray field while providing full field of view imaging. In this work, we investigated the magnitude of scatter dose reduction to staff made possible by using an ROI attenuator composed of 0.

The effect of pegbovigrastim administration on the nonspecific immunity of calves.

Background: Prevention of diseases in the early rearing of calves is important, particularly because disease occurrence most often requires antimicrobial administration but reduction of their use in animals is a priority. Pegbovigrastim is known for its use as an immunoregulator in cows and heifers, but the effect of its administration on calves has not been fully investigated.

Objectives: Investigate whether administration of pegbovigrastim effectively stimulates nonspecific immunity in healthy calves.